While HER2 gene amplification is the primary mechanism responsible for HER2 overexpression in most HER2-positive cancers, except in lung cancer (Ren et al., 2022), high transcription rates of HER2 per gene copy have also been observed to contribute (Liu et al., 2018). Here, ERBB2 is linked to cancer.